Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,041.60
(
-0.62%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
99.00
(
2.35%
)
Bitcoin
77,628.71
(
-0.78%
)
News Focus
News Focus
Post# of 822498
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: dennisdave post# 773196

Saturday, 06/28/2025 1:09:24 PM

Saturday, June 28, 2025 1:09:24 PM

Post# of 822498

The guidance highlights situations where RCTs are unethical or unfeasible, such as:
There are over a dozen large randomized trials in GBM running as we speak.

Start with this 672 patient trial with a personalited DC vaccine.

Or of course Keynote D58., a 790 patient trial with TTF plus Keytruda that Merck is colloborating on.

Why is it others can run these trials and NWBO can't?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News